MedTrace Logo

Electromagnetic Stimulation (FREMS) in Patients With Painful Diabetic Neuropathy

NCT00337324 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2006-06-15

No results posted yet for this study

Summary

We postulate that frequency-modulated electromagnetic stimulation (FREMS) may decrease pain in patients with painful diabetic neuropathy.

Conditions

  • Painful Diabetic Neuropathy

Interventions

DEVICE

Frequency-modulated electromagnetic neural stimulation

Sponsors & Collaborators

  • Lorenz Biotech S.p.A.

    collaborator INDUSTRY

  • University Of Perugia

    collaborator OTHER

  • IRCCS San Raffaele

    lead OTHER

Principal Investigators

  • Emanuele Bosi, MD · San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milano (Italy)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-03-31
Completion
2004-05-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00337324 on ClinicalTrials.gov